Definitive contract W81XWH19C0193EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Overview
Award facts
- Net obligations
- $5.72M
- $5,721,771of $5.72M potential value
- Outlays (paid to date)
- $0
- $0 paid of $5.72M obligated$0
- Period of performance
- Sep 26, 2019 to Feb 29, 2024
- Ended
- Modifications
- 13
- Latest action Jul 17, 2024
- Contract type
- Definitive contract
- PIID W81XWH19C0193
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM.
Dates and value
- Award date
- Signed on Sep 26, 2019
- Potential end of performance
- Feb 28, 2024
- Current value
- $5,721,771Base and exercised options
- Potential value (if all options are exercised)
- $5,721,771
Obligations by fiscal year of action
- FY2024: -$1,138,106 (de-obligation)
- FY2023: -$4,200,843 (de-obligation)
- FY2021: $5,396,498
- FY2019: $5,664,222
Total across 4 fiscal years: $5,721,771
Net de-obligation in that fiscal year (obligations withdrawn).
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 19, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 17, 2024. View on USAspending · Recipient on SAM.gov
Recipient
Business types and certifications
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Department Of The Army
- W4PZ USA MED RSCH ACQUIS ACT
- Funded by
- Department of Defense
- Defense Health Agency
- ARMY MMDA - MM
- Funded from
- Rdt&e; Research development test and evaluation; N/a; UndistributedProgram activities097-0130Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Gaithersburg, Montgomery County, Maryland 20879-3419
- Congressional district (place of performance)
- MD-06As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN93R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- W81XWH19R0032
- Solicitation date
- May 21, 2019
- Notices
- Combined Synopsis/Solicitation posted Jun 4, 2019
- Combined Synopsis/Solicitation posted May 21, 2019
Contract details
- Subcontracting plan
- Individual subcontract planF
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- Yes
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 26, 2019Base obligation at award: $5,664,222
- Latest action
- Jul 17, 2024 — Supplemental agreement (within scope)Modification P00013; obligation change -$1,138,106
- Latest substantive action
- Jul 17, 2024 — Supplemental agreement (within scope)Modification P00013; obligation change -$1,138,106
- Latest funding action
- Mar 31, 2023 — Funding onlyModification P00011; obligation change -$6,787,812; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Supplemental agreement (within scope)7
- Funding only3
- Other administrative action3
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$1,138,106
- Latest action: change in base and all options
- -$1,138,106
Socio-economic and policy
- Inherently governmental functions
- Closely associatedCL
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- Yes
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
- Sea transportation
- UnknownU
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- IT commercial item category
- Not IT products or servicesZ
- DoD claimant program
- ServicesS1
- Awarding agency code
- 9700
- Awarding sub-tier code
- 2100
- Contracting office code
- W81XWH
- Transactions recorded under this award key
- 14
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 97DH
- Funding office code
- HT0986
- Treasury accounts
- 097-2018/2019-0130-000
- 097-2020/2021-0130-000
- 097-2021/2022-0130-000
- 097-2022/2023-0130-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression